Effective Doses of Low-Dose Naltrexone for Chronic Pain – An Observational Study
Effective Doses of Low-Dose Naltrexone for Chronic Pain – An Observational Study Norman Marcus et al. 21st March 2024 https://doi.org/10.2147/JPR.S451183 Purpose: Despite the availability of a wide variety of analgesics, many patients with chronic pain often experience suboptimal pain relief in part related to the absence of any medication to address the nociplastic component of […]
Naltrexone 6 mg Once Daily Versus Placebo in Women with Fibromyalgia: A Randomised, Double-Blind, Placebo-Controlled Trial (Abstract)
Naltrexone 6 mg Once Daily Versus Placebo in Women with Fibromyalgia: A Randomised, Double-Blind, Placebo-Controlled Trial 1 Background Low-dose naltrexone is used to treat fibromyalgia despite minimal evidence for its efficacy. This trial aimed to investigate whether 12-week treatment with 6 mg low-dose naltrexone was superior to placebo for reducing pain in women with fibromyalgia. Methods […]
Treatment of dissociative symptoms with opioid antagonists: a systematic review (Abstract)
Treatment of dissociative symptoms with opioid antagonists: a systematic review Eur J Psychotraumatol 20 October 2023 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591526/ Background: The clinical guidelines for the treatment of dissociation focus primarily on psychotherapy. However, different psychoactive drugs are used in clinical practice. The use of opioid antagonists has been proposed as a therapeutic option based on the theory […]
Is Fibromyalgia a Fashionable Diagnosis or a Medical Mystery? (Abstract)
Is Fibromyalgia a Fashionable Diagnosis or a Medical Mystery? Cureus 07 September 2023 https://pubmed.ncbi.nlm.nih.gov/37809234/ Despite its prevalence, there is no clear-cut diagnostic path or treatment paradigm for fibromyalgia; this can lead to a multiplicity of symptoms and comorbid conditions that complicate care. “Overlapping symptoms” describe conditions that can occur concomitantly with fibromyalgia and include migraine, […]
Patients’ Perspective, Quality of Life and Treatment Goals in Hailey-Hailey Disease… (Abstract)
Patients’ Perspective, Quality of Life and Treatment Goals in Hailey-Hailey Disease: lessons learned from the German National Registry J Eur Acad Dermatol Venereol 20 October 2023 https://pubmed.ncbi.nlm.nih.gov/37863661/ Background: Hailey-Hailey disease (HHD) remains a difficult-to-treat dermatosis and little is known about the patient’s perception of the disease activity, the treatment success, and its impact on quality-of-life […]
Low-dose naltrexone use for the management of post-acute sequelae of COVID-19 (Abstract)
Low-dose naltrexone use for the management of post-acute sequelae of COVID-19 Int Immunopharmacol 05 October 2023 https://pubmed.ncbi.nlm.nih.gov/37804660/ The global prevalence of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) stands at approximately 43 % among individuals who have previously had acute COVID-19. In contrast, in the United States, the National Center for Health Statistics (NCHS) estimates that […]
Complex Presentations, Identification and Treatment of Mast Cell Activation Syndrome… (Abstract)
Complex Presentations, Identification and Treatment of Mast Cell Activation Syndrome and Associated Conditions: A Case Report Integr Med (Encinitas) September 2023 https://pubmed.ncbi.nlm.nih.gov/37752934/ Mast Cell Activation Syndrome (MCAS) is only a recently recognized, multisystem disorder that has been historically underrecognized due its estimated high prevalence. Recognition, testing, and treatment all pose unique challenges to condition management. […]
Is low-dose naltrexone effective in chronic pain management? (Abstract)
Is low-dose naltrexone effective in chronic pain management? J Fam Pract September 2023 https://pubmed.ncbi.nlm.nih.gov/37729143/ YES. Low-dose naltrexone is as effective as amitriptyline in the treatment of painful diabetic neuropathy and has a superior safety profile (strength of recommendation [SOR], B; single randomized controlled trial [RCT]). Low-dose naltrexone significantly reduced pain by 32% in inflammatory conditions […]
Combination therapy: A New Tool for the Management of Obesity (Abstract)
Combination therapy: A New Tool for the Management of Obesity Endocr Metab Immune Disord Drug Targets 25 August 2023 https://pubmed.ncbi.nlm.nih.gov/37641995/ Obesity is a long-term lifestyle problem that can lead to disastrous consequences. Lifestyle interventions are one of the initial lines of management strategies for obesity but in long term, it is not very effective in […]
Low-Dose Naltrexone Use in Postural Orthostatic Tachycardia Syndrome… (Abstract)
Low-Dose Naltrexone Use in Postural Orthostatic Tachycardia Syndrome: A Case Series Cureus 13 August 2023 https://www.cureus.com/articles/176869-low-dose-naltrexone-use-in-postural-orthostatic-tachycardia-syndrome-a-case-series#!/ Introduction: In recent years, low-dose naltrexone has emerged as a novel off-label therapy for many chronic conditions including postural orthostatic tachycardia syndrome (POTS), however, there is little evidence for its efficacy. Methods: In this institutional review board (IRB)-approved case series, the […]